Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis.
about
Evidence from Human and Animal Studies: Pathological Roles of CD8(+) T Cells in Autoimmune Peripheral NeuropathiesInflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention.Serine-1321-independent regulation of the mu 1 adult skeletal muscle Na+ channel by protein kinase CNovel therapeutic approaches to Guillain-Barré syndrome.Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis.T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype.Therapeutic apheresis in neurology critical care.Guillain-Barré syndrome: update on immunobiology and treatment.Novel treatment for immune neuropathies on the horizon.Advances in the diagnosis, pathogenesis and treatment of CIDP.Targeted immunotherapy trials for idiopathic inflammatory myopathies.Recent developments and future directions in Guillain-Barré syndrome.IL-3-LA production by mononuclear cells of patients with multiple sclerosis: effect of treatment with intravenous immunoglobulins.Soluble interleukin-2 receptor levels in serum of patients with demyelinating polyneuropathy associated with monoclonal gammopathy.Guillain-Barré syndrome in immunocompromised patients: a report of three patients and review of the literature.Circulating transforming growth factor beta 1 (TGF-beta1) in Guillain-Barré syndrome: decreased concentrations in the early course and increase with motor function.Tumour necrosis factor-alpha and other cytokines in Guillain-Barré syndrome.Leprosy with Guillain Barre Syndrome: a new neurologic manifestation?CIDP and other inflammatory neuropathies in diabetes - diagnosis and management.Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10.Diagnostic insights into chronic-inflammatory demyelinating polyneuropathies
P2860
Q26777185-4FE3AEB7-0541-4D4E-9013-95E3AB08A517Q27322544-D4BBCC35-4749-44C8-A9E3-CE2E7DF60C0CQ33638979-17BC40DE-CB9A-4F6F-86C6-4CA2115328DBQ34075115-06FF092D-0343-4CBF-B3D9-97B2393CB835Q34503367-5A806D47-940C-4A72-931D-1F6401A20556Q35484496-AD6AAA4B-4C7F-4DE4-9FF0-E8BA519094BBQ36005389-CC8CACC1-8BF0-4F3E-B795-1CB25B0E14ECQ36215377-7CBE4995-3AA1-413C-A49A-DCBB30C5C40DQ37600859-EF9A8281-29B4-4429-918C-CB54B47F6E20Q37892641-031D2005-6DD0-41B1-B874-9C6064351530Q37918316-652A404A-F2BD-4A9A-830F-26C2F1FD323CQ38023207-712F9098-D9DD-4F05-9494-9FC4EBD352F9Q38070887-186342B3-907C-49F3-849B-8D2A4B279627Q41315054-99C7EA27-B8F8-4DBF-B5D6-15C99CB19C7CQ41385841-A2C232FA-F203-415F-9759-1258760BAB61Q41543833-0A6F472F-CF25-4BFA-9191-8DE202693002Q42123972-BD45A8C7-34CB-4992-A73B-21F87A5E3F43Q42714037-59E7675C-22D6-4F72-B8B1-9FEFBAE6D794Q44908651-4F7A84C0-63ED-472B-A05C-3FBCF5CEA476Q47978955-BF6753EA-52F8-4D37-8897-7391C69650E4Q48651342-1E9EDBFF-7F21-4746-BA0E-562827FAC071Q57300562-7FF94E4B-EC26-49D0-8C80-1C768314596B
P2860
Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Serum interleukin-2 concentrat ...... f presumed immunopathogenesis.
@en
Serum interleukin-2 concentrat ...... f presumed immunopathogenesis.
@nl
type
label
Serum interleukin-2 concentrat ...... f presumed immunopathogenesis.
@en
Serum interleukin-2 concentrat ...... f presumed immunopathogenesis.
@nl
prefLabel
Serum interleukin-2 concentrat ...... f presumed immunopathogenesis.
@en
Serum interleukin-2 concentrat ...... f presumed immunopathogenesis.
@nl
P2093
P2860
P356
P1433
P1476
Serum interleukin-2 concentrat ...... f presumed immunopathogenesis.
@en
P2093
P2860
P356
10.1002/ANA.410300110
P577
1991-07-01T00:00:00Z